BFAR anticorps (C-Term)
Aperçu rapide pour BFAR anticorps (C-Term) (ABIN499449)
Antigène
Voir toutes BFAR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- BFAR antibody was raised against a 14 amino acid peptide near the carboxy terminus of human BFAR.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
ELISA. Western Blot: BFAR antibody can be used for detection of BFAR at 1 - 2 μg/mL. Immunohistochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store the antibody (in aliquots) at -20 °C.
-
-
- BFAR (Bifunctional Apoptosis Regulator (BFAR))
-
Autre désignation
- BFAR / RNF47
-
Sujet
- The bifunctional apoptosis inhibitor (BFAR) is scaffold protein that integrates signaling components of the cells apoptosis-regulatory machinery. BFAR is a multidomain protein capable of inhibiting apoptosis induced by TNF-family death receptors (extrinsic pathway) as well as mitochondria-dependent apoptosis (intrinsic pathway). Interaction of BFAR with Bcl-2 or Bcl-XL via a SAM domain may contribute to the anti-apoptotic properties of BFAR. In addition, BFAR contains a DED-like domain that is capable of suppressing apoptosis mediated at the receptor level. BFAR is also thought to be involved in the regulation of neuronal survival.Synonyms: BAR, Bifunctional apoptosis regulator, RING finger protein 47
-
ID gène
- 51283
-
NCBI Accession
- NP_057645
-
UniProt
- Q9NZS9
Antigène
-